序号 |
标题 |
次数 |
作者 |
发布时间 |
74161 |
DOTA-PESIN 金属螯合剂DOTA偶联多肽 |
86 |
h |
2024-12-19 |
74162 |
(Ac)Phe-Lys(Alloc)-PABC-PNP, ADC试剂 |
73 |
kx |
2024-12-19 |
74163 |
Mal-PEG8-Val-Cit-PAB-PNP,C47H67N9O19 |
135 |
WYQ |
2024-12-19 |
74164 |
DBCO-PEG3-Val-Cit-PAB-PNP,ADC定制 |
82 |
wyh |
2024-12-19 |
74165 |
[d-Phe7]-α-MSH3-10 |
96 |
h |
2024-12-19 |
74166 |
cas:863971-53-3,Fmoc-Val-Cit-PAB-PNP, ADC试剂 |
99 |
kx |
2024-12-19 |
74167 |
CAS: 2055041-37-5, Mal-PEG1-Val-Cit-PAB-OH(有时也被称为Mal-PEG1-Val-Cit-PABC-OH) |
82 |
WYQ |
2024-12-19 |
74168 |
Mal-L-PA-NH-Boc CAS:1491152-23-8 |
76 |
zyl |
2024-12-19 |
74169 |
cas:2504147-53-7 ,Mal-amido-PEG2-Val-Cit-PAB-OH,ADC定制 |
84 |
wyh |
2024-12-19 |
74170 |
Mal-PEG1-Val-Cit-OH,马来酰亚胺-一聚乙二醇-VAL-CIT-羟基 |
85 |
WYQ |
2024-12-19 |
74171 |
cas:1342820-51-2,SGD-1910, ADC试剂 |
107 |
kx |
2024-12-19 |
74172 |
Ald-Ph-amido-PEG2-C2-Pfp ester CAS:2101206-60-2 |
92 |
zyl |
2024-12-19 |
74173 |
cas:1228105-52-9,DM4-SMCC, ADC试剂 |
100 |
kx |
2024-12-19 |
74174 |
马来酰亚胺-八聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP酯,ADC定制 |
90 |
wyh |
2024-12-19 |
74175 |
cas:863971-56-6,Val-Cit-PAB-MMAF, ADC试剂 |
68 |
kx |
2024-12-19 |
74176 |
SPDMB CAS:2101206-29-3合成方法 |
86 |
zyl |
2024-12-19 |
74177 |
cas:2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH,ADC定制 |
81 |
wyh |
2024-12-19 |
74178 |
cas:1347750-81-5,Mal-NH-PEG2-CH2CH2COOPFP ester, ADC试剂 |
78 |
kx |
2024-12-19 |
74179 |
金属螯合剂DOTA偶联α-MSH八肽类似物 |
64 |
h |
2024-12-19 |
74180 |
cas:1286715-33-0,2,5-Dioxopyrrolidin-1-yl 4-methyl-4-((2-methyl-5-oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-yl)disulfanyl)pentanoate |
101 |
kx |
2024-12-19 |
74181 |
DOTA-conjugated multivalent cyclic-RGD DOTA-共轭多价环RGD肽树枝状大分子 |
69 |
h |
2024-12-19 |
74182 |
Azidoethyl-SS-ethylazide CAS:352305-38-5 |
78 |
zyl |
2024-12-19 |
74183 |
CAS: 870487-09-5, Boc-Val-Cit-PAB |
78 |
WYQ |
2024-12-19 |
74184 |
cas:2101206-67-9,Ald-Ph-amido-PEG1-C2-Pfp ester, ADC试剂 |
71 |
kx |
2024-12-19 |
74185 |
Ald-Ph-amido-PEG11-NH-Boc CAS:1245813-70-0 |
94 |
zyl |
2024-12-19 |
74186 |
HSA-2-iminothiolane-DOTA HSA-2-亚氨基硫醇-DOTA |
90 |
h |
2024-12-19 |
74187 |
cas:1222787-24-7,2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-oxobutanoate |
201 |
kx |
2024-12-19 |
74188 |
Tr-PEG5-OH CAS:141282-24-8物理化学性质 |
95 |
zyl |
2024-12-19 |
74189 |
CAS: 870487-08-4,Boc-Val-Cit,(S)-2-((S)-2-((叔丁氧基羰基)氨基)-3-甲基丁酰胺基)-5-脲基戊酸 |
95 |
WYQ |
2024-12-19 |
74190 |
DOTA-8-Aoc-BBN[7-14]NH |
102 |
h |
2024-12-19 |
74191 |
Fmoc-PEG3-Val-Cit,N-Fluorenylmethoxycarbonyl-triethylene glycol-Val-Cit |
81 |
WYQ |
2024-12-19 |
74192 |
CAS: 2226472-28-0,DBCO-PEG4-Val-Cit-PAB-PNP |
78 |
WYQ |
2024-12-19 |
74193 |
CAS: 2055024-64-9,Azido-PEG4-Val-Cit-PAB-OH |
80 |
WYQ |
2024-12-19 |
74194 |
CAS: 870487-09-5,Boc-Val-Cit-PAB |
84 |
WYQ |
2024-12-19 |
74195 |
CAS:784105-33-5 Amino-PEG3-C2-acid的介绍 |
72 |
zyl |
2024-12-19 |
74196 |
CAS 863971-53-3:Fmoc-Val-Cit-PAB-PNP |
87 |
WYQ |
2024-12-19 |
74197 |
Ald-Ph-amido-PEG11-C2-NH2 CAS:1337889-01-6 |
69 |
zyl |
2024-12-19 |
74198 |
cas:2003260-13-5 , MA-PEG4-Ala-Ala-PAB-PNP,ADC定制 |
72 |
wyh |
2024-12-19 |
74199 |
DOTA-NCS-6-Ahx-Phe 19-ST[1-19] DOTA偶联ST肽类似物 |
102 |
h |
2024-12-19 |
74200 |
1,4,7,10-四氮杂-n-(1-羧基-3-(4-硝基苯基)丙基)-n,N , N ‴-tris(acetic酸)环十二烷(PA-DOTA) |
67 |
h |
2024-12-19 |
74201 |
CAS 159858-22-7:Fmoc-Val-Cit-PAB-OH |
61 |
WYQ |
2024-12-19 |
74202 |
cas:5117-19-1,Octanethyl glycol ,八乙二醇的主要特点 |
97 |
zyl |
2024-12-19 |
74203 |
CAS 159857-79-1:Val-Cit-PAB-OH,缬氨酸(Val)、琥珀酰亚胺(Cit)和对氨基苯甲酸(PAB)的衍生物 |
101 |
WYQ |
2024-12-19 |
74204 |
SPDP-Val-Cit-PAB-OH,ADC定制 |
67 |
wyh |
2024-12-19 |
74205 |
DOTA-LVT 螯合剂DOTA偶联Lys8-血管收缩素 |
94 |
h |
2024-12-19 |